Skip to main content
Tags: genomic prostate score | facts

5 Facts About the Genomic Prostate Score

By    |   Tuesday, 16 February 2016 04:09 PM EST

Every 20 minutes in the U.S., a man dies from prostate cancer. The genomic prostate score (GPS) is an important way to better understand each individual’s cancer and determine the appropriate treatment path.

Here are some helpful facts about the genomic prostate score.

SPECIAL: The One Thing You Should Do for Your Prostate Every Morning

1. According to Zero Cancer, genomic testing relies on cancerous tissue samples taken from the prostate gland. The cells are analyzed to determine how aggressive a patient’s cancer is and how quickly it is likely to spread to other parts of the body.

2. The genomic prostate score is the result of a test called the Oncotype DX prostate cancer test, says MyProstateCancerTreatment.org. The score helps guide physicians in developing the best customized treatment plan for each patient.

3. MyProstateCancerTreatment.org explains that the genomic prostate score, together with another set of guidelines set forth by the National Comprehensive Cancer Network, are used to determine the level of risk for a patient’s prostate cancer. Very high-risk cancer patients are generally not candidates for the Oncotype DX test, however.

ALERT: Prostate Size Can Greatly Affect Quality of Life and Sleep. What Size Is Yours? See This Photo.

4. The University of California San Francisco says that for men with very low-risk, non-aggressive prostate cancer, a strategy called active surveillance is a viable approach. With active surveillance, the cancer is not actually treated. Instead it is closely monitored through blood tests and biopsies to determine if and when treatment becomes necessary. The genomic prostate score can help physicians determine which prostate cancer patients are good candidates for this approach, saving patients from the adverse side affects associated with invasive treatment.

Prostate cancer is a significant health concern for men. The Oncotype DX test and the genomic prostate score is an emerging means of assessing risk, customizing treatment plans, and ensuring that patients get the appropriate level of care for their cancer.

EDITOR'S NOTE: How One Household Plant Has Been Shown to Improve Prostate Function

© 2025 Newsmax. All rights reserved.


FastFeatures
Every 20 minutes in the U.S., a man dies from prostate cancer. The genomic prostate score (GPS) is an important way to better understand each individual's cancer and determine the appropriate treatment path.
genomic prostate score, facts
338
2016-09-16
Tuesday, 16 February 2016 04:09 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.

PLEASE NOTE: All information presented on Newsmax.com is for informational purposes only. It is not specific medical advice for any individual. All answers to reader questions are provided for informational purposes only. All information presented on our websites should not be construed as medical consultation or instruction. You should take no action solely on the basis of this publication’s contents. Readers are advised to consult a health professional about any issue regarding their health and well-being. While the information found on our websites is believed to be sensible and accurate based on the author’s best judgment, readers who fail to seek counsel from appropriate health professionals assume risk of any potential ill effects. The opinions expressed in Newsmaxhealth.com and Newsmax.com do not necessarily reflect those of Newsmax Media. Please note that this advice is generic and not specific to any individual. You should consult with your doctor before undertaking any medical or nutritional course of action.

 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved